Ryan M. Carnahan

The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

Ryan M. Carnahan, Brian C. Lund, Paul J. Perry et al. · The Journal of Clinical Pharmacology · 2006 · 662 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction

Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown et al. · Pharmacoepidemiology and Drug Safety · 2012 · 290 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Inappropriate Prescribing Predicts Adverse Drug Events in Older Adults

Brian C. Lund, Ryan M. Carnahan, J. K. Egge et al. · Annals of Pharmacotherapy · 2010 · 195 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +17

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer

Mark Stewart, Andrew D. Norden, Nancy A Dreyer et al. · JCO Clinical Cancer Informatics · 2019 · 134 citations · Full text

Medicine, Biostatistics, Oncology +17

The Concurrent Use of Anticholinergics and Cholinesterase Inhibitors: Rare Event or Common Practice?

Ryan M. Carnahan, Brian C. Lund, Paul J. Perry et al. · Journal of the American Geriatrics Society · 2004 · 120 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +8